Drug Topics
JANUARY 22, 2024
The Equitable Community Access to Pharmacist Services Act seeks to ensure that seniors in rural and underserved communities have access to care and services from pharmacists for common infectious diseases.
Pharmacy Times
JANUARY 22, 2024
The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 22, 2024
Of the 2596 patients included in the study, the hospitalization rates were 31.5% for Omicron, 27.7% for influenza, and 81.7% for RSV.
Pharmacy Times
JANUARY 22, 2024
Regardless of a pharmacist’s practice site or type, they play an integral role in ensuring the treatment success of patients with HIV.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JANUARY 22, 2024
America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. Each new round of boosters has drawn fewer bared arms than the round before it. The Centers for Disease Control and Prevention estimates that, as of Jan. 6, a mere 21.5% of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine.
Pharmacy Times
JANUARY 22, 2024
The IQVIA Global Use of Medicines report for 2024 predicts that loss of brand exclusivity will negatively impact global market growth.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
JANUARY 22, 2024
As many have feared, the FDA’s investigation into secondary T-cell cancers following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning. | As many have feared, the FDA's investigation into secondary T-cell malignancies following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning.
STAT
JANUARY 22, 2024
In June, the Food and Drug Administration issued a warning letter about advertisements for the drug Recorlev for Cushing’s syndrome — its first in more than a year about webpages that make “false or misleading claims” about prescription drugs. More recently, in December the agency published guidance about TV and radio advertisements.
Pharmacy Times
JANUARY 22, 2024
Berberine was associated with a reduction in inflammatory markers in the lungs, which was caused by the colorectal cancer.
STAT
JANUARY 22, 2024
BOSTON — Doctors often don’t have a lot of time to chat with patients during medical appointments — which means that conversations about nutrition can wind up taking a backseat to other concerns. But during a recent weeklong course at Harvard T.H. Chan School of Public Health, preventive cardiologist Stephen Devries enlisted two dozen students in the mission to integrate nutrition into clinical medicine — changing the way medicine is taught and health care is delivere
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
JANUARY 22, 2024
Even as Gilead looks to become an oncology powerhouse in the coming years, the company on Monday recorded a major setback for its antibody-drug conjugate (ADC) Trodelvy. | The antibody-drug conjugate did not significantly improve survival outcomes compared with a chemotherapy alone in previously treated patients with metastatic non-small cell lung cancer.
STAT
JANUARY 22, 2024
Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed. The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.
Pharmacy Times
JANUARY 22, 2024
The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.
STAT
JANUARY 22, 2024
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer that had metastasized into some of his bones. He welcomed the treatment, but was surprised by the $740 monthly copay cost, even after coverage from Medicare and supplemental insurance. So Sachs began reading about the drug, Xtandi , and found the annual list price at the time was about $156,000, or $427 a day, for men with commercial health insurance.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
JANUARY 22, 2024
Eli Lilly’s beleaguered manufacturing site in Branchburg, New Jersey, is back in the U.S. Food and Drug Administration’s crosshairs, Reuters first reported. | Following a July inspection, the FDA has uncovered eight new production deficiencies at Eli Lilly's Branchburg production plant. The observations run the gamut from problems in tracking manufacturing processes and quality controls to equipment calibration lapses and poor facility maintenance.
STAT
JANUARY 22, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Summa wrestling for physician buy-in General Catalyst finally has the hospital system it wants. But there’s some skepticism that the venture capital firm will live up to its promises and get the required buy-in from physicians and other medical staff, my colleague Tara Bannow reports.
Fierce Healthcare
JANUARY 22, 2024
The digital health and health tech sectors had a tough year in the wake of the COVID-19 pandemic, navigating through a turbulent hype cycle. | This week on "Podnosis," Sofia Guerra and Steve Kraus from Bessemer Venture Partners sat down with Fierce Healthcare's Heather Landi to discuss the health tech sector's performance, unraveling the factors that contributed to its current state.
STAT
JANUARY 22, 2024
The human blood system is in a constant state of turnover. First-line immune defenders, like neutrophils, need to be replaced after just four to eight hours, platelets can last a week, red blood cells up to four months, and some white blood cells, like memory B cells, live for decades. The heroic task of constantly replenishing these ranks, and making sure the balance of different types of blood cells is right, falls to a primitive reserve of stem cells that reside deep in the bone marrow.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 22, 2024
This startup is building a new model for primary and specialty care in Austin, Texas. It just secured $95.
STAT
JANUARY 22, 2024
WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday. The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility.
Pharmacy Times
JANUARY 22, 2024
Experts discuss the impact of advances in the treatment of multiple myeloma on patient care.
pharmaphorum
JANUARY 22, 2024
Sandoz makes its first acquisition since spinning out of Novartis, buying a Lucentis biosimilar from Coherus that will boost its position in the US market.
Pharmacy Times
JANUARY 22, 2024
Access to gene therapies can pose challenges for patients.
STAT
JANUARY 22, 2024
Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions between different drugs. Having all of these details in accessible, printed documents keeps patients informed and mitigates the risk of medication errors. However, there’s a growing movement across the world to eliminate printed medication information, making it harder for patients to learn about the drugs that, in many cases, save their lives.
Pharmacy Times
JANUARY 22, 2024
There is a significant efficacy-effectiveness gap in standard-of-care regimens.
pharmaphorum
JANUARY 22, 2024
Pharma waste management is crucial for balancing cost, compliance, and environmental responsibility in the healthcare industry. Explore strategies and best practices for effectively managing pharmaceutical waste, while ensuring regulatory compliance and minimising environmental impact.
Pharmacy Times
JANUARY 22, 2024
Infection-induced immunity with 2-dose vaccination still offered protection against the circulating variant.
The Checkup by Singlecare
JANUARY 22, 2024
Cholesterol gets a bad rap, but the truth is that your body needs cholesterol. The health issue that arises for many people is when levels get out of whack—meaning, your “bad” cholesterol is too high while the “good” kind is too low. Lots of factors can affect cholesterol levels, including drinking alcohol. But if you’re keeping an eye on your cholesterol levels, does this mean you can never have a drink?
Fierce Pharma
JANUARY 22, 2024
When the FDA converts an accelerated approval into a full nod, it’s typically associated with a wider label for the drug at hand. | When the FDA converts an accelerated approval into a full nod, it's typically associated with a wider label for the drug at hand. But in the case of Johnson & Johnson’s Balversa, the FDA narrowed the use of the first-in-class bladder cancer drug in two ways and expanded it in another.
Drug Store News
JANUARY 22, 2024
Sri Narasimhan, VP and head of enterprise customer experience at CVS Health, discusses using a customer-centric approach to cultivate higher retail pharmacy expectations among the public.
STAT
JANUARY 22, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because now the time has come to dive back in to the usual routine of online meetings, calls, and deadlines. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation.
pharmaphorum
JANUARY 22, 2024
End of the line for Roche’s 18-year alliance with Swiss biotech AC Immune, as it returns rights to Alzheimer's antibodies crenezumab and semorinemab
Drug Store News
JANUARY 22, 2024
Valentineâs Day is just weeks away and Hostess is showing off some of its holiday-inspired treats, which include a Twinkies gift box.
Expert insights. Personalized for you.
224 
Let's personalize your content